SCHEMBL20871352

SCHEMBL20871352

C#CC(=O)Oc1ccccc1C(=O)Oc1cccc(CO[N+](=O)[O-])c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 3/20 0.41
KMT2A Q03164 5/20 0.40
ALDH1A1 P00352 3/20 0.40
HSD17B10 Q99714 2/20 0.40
TSHR P16473 1/20 0.40
MEN1 O00255 3/20 0.38
MAPT P10636 2/20 0.38
RAB9A P51151 1/20 0.38
ALOX5 P09917 2/20 0.38
F2 P00734 1/20 0.37
ESR1 P03372 2/20 0.36
ESR2 Q92731 1/20 0.36
TMEM97 Q5BJF2 2/20 0.36
MAOB P27338 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
GAA P10253 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20871763 0.86 PTGS2 (0.43) PTGS2KMT2AALDH1A1HSD17B10TSHR
Ncx-4016 SCHEMBL19524 0.86 PTGS2 (0.57) PTGS2KMT2AALDH1A1HSD17B10TSHR
Ncx-4016 SCHEMBL29546681 0.86 PTGS2 (0.57) PTGS2KMT2AALDH1A1HSD17B10TSHR
Ncx-4016 SCHEMBL29813476 0.86 PTGS2 (0.57) PTGS2KMT2AALDH1A1HSD17B10TSHR
SCHEMBL2300089 0.82 HPGD (0.54) KMT2AALDH1A1HSD17B10TSHRMAPT
SCHEMBL20871331 0.81 PTGS2 (0.39) PTGS2KMT2AALDH1A1HSD17B10TSHR
SCHEMBL12268187 0.80 KMT2A (0.49) PTGS2KMT2AALDH1A1HSD17B10MEN1
SCHEMBL15928874 0.77 KMT2A (0.39) PTGS2KMT2AALDH1A1HSD17B10TSHR
SCHEMBL14010493 0.76 KDM4E (0.46) PTGS2KMT2AALDH1A1HSD17B10TSHR
SCHEMBL15928965 0.76 KMT2A (0.38) PTGS2KMT2AALDH1A1HSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3692014-B1 PROBE FOR SELECTIVELY CHARACTERIZING ENZYMES INVOLVED IN XENOBIOTIC METABOLISM AND METHOD OF MAKING AND USING THE SAME BATTELLE MEMORIAL INSTITUTE (US) 2023-11-22 EP disclosed
US-11345950-B2 Probe for selectively characterizing enzymes involved in xenobiotic metabolism and method of making and using the same BATTELLE MEMORIAL INSTITUTE (US) 2022-05-31 US disclosed
WO-2019069297-A2 PROBE FOR SELECTIVELY CHARACTERIZING ENZYMES INVOLVED IN XENOBIOTIC METABOLISM AND METHOD OF MAKING AND USING THE SAME KILLINGER, BYRAN J. (US) 2019-04-11 WO disclosed
WO-2019070906-A1 PROBE FOR SELECTIVELY CHARACTERIZING ENZYMES INVOLVED IN XENOBIOTIC METABOLISM AND METHOD OF MAKING AND USING THE SAME WRIGHT AARON T (US) 2019-04-11 WO disclosed
US-20190100792-A1 PROBE FOR SELECTIVELY CHARACTERIZING ENZYMES INVOLVED IN XENOBIOTIC METABOLISM AND METHOD OF MAKING AND USING THE SAME BATTELLE MEMORIAL INSTITUTE 2019-04-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11345950-B2 Probe for selectively characterizing enzymes involved in xenobiotic metabolism and method of making and using the same CYP2E1, CYP1A1, CYP7A1 PTGS2 1867/4885KMT2A 3560/4885ALDH1A1 150/4885
US-20190100792-A1 PROBE FOR SELECTIVELY CHARACTERIZING ENZYMES INVOLVED IN XENOBIOTIC METABOLISM AND METHOD OF MAKING AND USING THE SAME CYP2E1, CYP1A1, CYP7A1 PTGS2 1867/4885KMT2A 3560/4885ALDH1A1 150/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.